zonisamide has been researched along with Hemolysis in 1 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakatsuji, K | 1 |
| Matsuno, Y | 1 |
| Nakamura, N | 1 |
| Fujitani, B | 1 |
| Ito, T | 1 |
| Kadokawa, T | 1 |
1 other study available for zonisamide and Hemolysis
| Article | Year |
|---|---|
General pharmacology of the novel antiepileptic compound zonisamide. 2nd communication: effects on cardiovascular, visceral, renal and blood functions.
Topics: Animals; Anticonvulsants; Autonomic Nervous System; Blood Coagulation; Cats; Digestive System; Dogs; | 1987 |